METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Target immune cell therapy fights tough liver cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for adults with advanced liver cancer that has stopped responding to standard treatments. Researchers are using specially engineered immune cells (CAR-NK cells) designed to recognize and attack cancer cells using two di…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Apr 04, 2026 02:05 UTC
-
Scientists reprogram Patients' own cells to fight advanced liver cancer
Disease control Recruiting nowThis early-stage trial is testing a new personalized treatment called ECT204 T-cell therapy for adults with advanced liver cancer (hepatocellular carcinoma) that has not responded to at least two other treatments. Doctors collect a patient's own immune cells, genetically modify t…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for tough cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis is the first human study of an experimental drug called ERX-315 for people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find a safe dose and understand how the body processes the drug. Researchers will also look for earl…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: EtiraRx Australia Pty Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC